|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:3429–34. 2019. View Article : Google Scholar
|
|
2
|
Zhao L, Wang W, Huang S, Yang Z, Xu L,
Yang Q, Zhou X, Wang J, Shen Q, Wang C, et al: The RNA binding
protein SORBS2 suppresses metastatic colonization of ovarian cancer
by stabilizing tumor-suppressive immunomodulatory transcripts.
Genome Biol. 19:352018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: lncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang W, Yang J, Xiang YY, Pi J and Bian J:
Overexpression of hsa-miR-320 is associated with invasion and
metastasis of ovarian cancer. J Cell Biochem. 118:3654–3661. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao L, Zheng M, Guo Q, Nie X, Li X, Hao Y,
Liu J, Zhu L and Lin B: Downregulation of Rab23 inhibits
proliferation, invasion, and metastasis of human ovarian cancer.
Int J Biochem Cell Biol. 116:1056172019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhan L, Li J and Wei B: Long non-coding
RNAs in ovarian cancer. J Exp Clin Cancer Res. 37:1202018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bu D, Luo H, Jiao F, Fang S, Tan C, Liu Z
and Zhao Y: Evolutionary annotation of conserved long non-coding
RNAs in major mammalian species. Sci China Life Sci. 58:787–798.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen QN, Chen X, Chen ZY, Nie FQ, Wei CC,
Ma HW, Wan L, Yan S, Ren SN and Wang ZX: Long intergenic non-coding
RNA 00152 promotes lung adenocarcinoma proliferation via
interacting with EZH2 and repressing IL24 expression. Mol Cancer.
16:172017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nolte W, Weikard R, Brunner RM, Albrecht
E, Hammon HM, Reverter A and Kühn C: Biological network approach
for the identification of regulatory long non-coding RNAs
associated with metabolic efficiency in cattle. Front Genet.
10:11302019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao Z, Xiong Z, Li R, Liang H, Jia C and
Deng M: Long non-coding RNA NRON is downregulated in HCC and
suppresses tumour cell proliferation and metastasis. Biomed
Pharmacother. 104:102–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zou T, Wang PL, Gao Y and Liang WT: Long
noncoding RNA HOTTIP is a significant indicator of ovarian cancer
prognosis and enhances cell proliferation and invasion. Cancer
Biomark. 25:133–139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitra R, Chen X, Greenawalt EJ, Maulik U,
Jiang W, Zhao Z and Eischen CM: Decoding critical long non-coding
RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat
Commun. 8:16042017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie Q, Lin S, Zheng M, Cai Q and Tu Y:
Long noncoding RNA NEAT1 promotes the growth of cervical cancer
cells via sponging miR-9-5p. Biochem Cell Biol. 97:100–108. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia Y, Zhou Y, Han H, Li P, Wei W and Lin
N: lncRNA NEAT1 facilitates melanoma cell proliferation, migration,
and invasion via regulating miR-495-3p and E2F3. J Cell Physiol.
234:19592–19601. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding F, Lai J, Gao Y, Wang G, Shang J,
Zhang D and Zheng S: NEAT1/miR-23a-3p/KLF3: A novel regulatory axis
in melanoma cancer progression. Cancer Cell Int. 19:2172019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H, Cai Y, Zheng L, Zhang Z, Lin X
and Jiang N: Long noncoding RNA NEAT1 regulate papillary thyroid
cancer progression by modulating miR-129-5p/KLK7 expression. J Cell
Physiol. 233:6638–6648. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aiello NM and Kang Y: Context-dependent
EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiang W, Lv L, Zhou G, Wu W, Yuan J, Zhang
C and Jiang G: The lncRNA SNHG5-mediated miR-205-5p downregulation
contributes to the progression of clear cell renal cell carcinoma
by targeting ZEB1. Cancer Med. 9:4251–4264. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abdul S, Majid A, Wang J, Liu Q, Sun MZ
and Liu S: Bidirectional interaction of lncRNA AFAP1-AS1 and CRKL
accelerates the proliferative and metastatic abilities of
hepatocarcinoma cells. J Adv Res. 24:121–130. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Yao HR, Liu SK and Song LL: Long
noncoding RNA ROR1-AS1 overexpression predicts poor prognosis and
promotes metastasis by activating Wnt/β-catenin/EMT signaling
cascade in cervical cancer. Eur Rev Med Pharmacol Sci.
24:2928–2937. 2020.PubMed/NCBI
|
|
23
|
Lai X, Eberhardt M, Schmitz U and Vera J:
Systems biology-based investigation of cooperating microRNAs as
monotherapy or adjuvant therapy in cancer. Nucleic Acids Res.
47:7753–7766. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilk G and Braun R: Integrative analysis
reveals disrupted pathways regulated by microRNAs in cancer.
Nucleic Acids Res. 46:1089–1101. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei L, Wang X, Lv L, Liu J, Xing H, Song
Y, Xie M, Lei T, Zhang N and Yang M: The emerging role of microRNAs
and long noncoding RNAs in drug resistance of hepatocellular
carcinoma. Mol Cancer. 18:1472019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Dun Y, Zhou S and Huang XH:
lncRNA HOXD-AS1 promotes epithelial ovarian cancer cells
proliferation and invasion by targeting miR-133a-3p and activating
Wnt/β-catenin signaling pathway. Biomed Pharmacother. 96:1216–1221.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Huang Y, Deng X, Luo M, Wang X, Hu
H, Liu C and Zhong M: Long noncoding RNA H19 promotes transforming
growth factor-β-induced epithelial-mesenchymal transition by acting
as a competing endogenous RNA of miR-370-3p in ovarian cancer
cells. Onco Targets Ther. 11:427–440. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colombo N, Sessa C, du Bois A, Ledermann
J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I,
Vergote I, et al: ESMO-ESGO consensus conference recommendations on
ovarian cancer: Pathology and molecular biology, early and advanced
stages, borderline tumours and recurrent disease†. Ann Oncol.
30:672–705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kiener TK, Selptsova-Friedrich I and
Hunziker W: Tjp3/zo-3 is critical for epidermal barrier function in
zebrafish embryos. Dev Biol. 316:36–49. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kausalya PJ, Reichert M and Hunziker W:
Connexin 45 directly binds to ZO-1 and localizes to the tight
junction region in epithelial MDCK cells. FEBS Lett. 505:92–96.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haskins J, Gu L, Wittchen ES, Hibbard J
and Stevenson BR: ZO-3, a novel member of the MAGUK protein family
found at the tight junction, interacts with ZO-1 and occludin. J
Cell Biol. 141:199–208. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim SG, Yooun JH, Kim DE, Lee ES, Kwon TK,
Kim S and Park JW: A novel anti-cancer agent, FPDHP, induces
anoikis in various human cancer cells through activation of
calpain, and downregulation of anoikis-related molecules. J Cell
Biochem. 119:5620–5631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martin TA, Mason MD and Jiang WG: HGF and
the regulation of tight junctions in human prostate cancer cells.
Oncol Rep. 32:213–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paschoud S, Bongiovanni M, Pache JC and
Citi S: Claudin-1 and claudin-5 expression patterns differentiate
lung squamous cell carcinomas from adenocarcinomas. Mod Pathol.
20:947–954. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martin TA, Watkins G, Mansel RE and Jiang
WG: Loss of tight junction plaque molecules in breast cancer
tissues is associated with a poor prognosis in patients with breast
cancer. Eur J Cancer. 40:2717–2725. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Colas E, Perez C, Cabrera S, Pedrola N,
Monge M, Castellvi J, Eyzaguirre F, Gregorio J, Ruiz A, Llaurado M,
et al: Molecular markers of endometrial carcinoma detected in
uterine aspirates. Int J Cancer. 129:2435–2444. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Wang Y, Fu X and Lu Z: Long
non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis
through regulation of miR-382-3p/ROCK1 axial. Cancer Sci.
109:2188–2198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen ZJ, Zhang Z, Xie BB and Zhang HY:
Clinical significance of up-regulated lncRNA NEAT1 in prognosis of
ovarian cancer. Eur Rev Med Pharmacol Sci. 20:3373–3377.
2016.PubMed/NCBI
|
|
39
|
Liu S, Tang J, Huang L, Xu Q, Ling X and
Liu J: Cordyceps militaris alleviates severity of murine acute lung
injury through miRNAs-mediated CXCR2 inhibition. Cell Physiol
Biochem. 36:2003–2011. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu F, Xiong Y, Zhao Y, Tao L, Zhang Z,
Zhang H, Liu Y, Feng G, Li B, He L, et al: Identification of
aberrant microRNA expression pattern in pediatric gliomas by
microarray. Diagn Pathol. 8:1582013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou KR, Liu S, Cai L and Bin L: ENCORI:
The Encyclopedia of RNA Interactomes. http://starbase.sysu.edu.cn/index.phpApril
15–2020
|
|
43
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan
C, Xu M, Sun H, Liu C, Wei P and Du X: The lncRNA NEAT1 activates
Wnt/β-catenin signaling and promotes colorectal cancer progression
via interacting with DDX5. J Hematol Oncol. 11:1132018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dong P, Xiong Y, Yue J, Xu D, Ihira K,
Konno Y, Kobayashi N, Todo Y and Watari H: Long noncoding RNA NEAT1
drives aggressive endometrial cancer progression via
miR-361-regulated networks involving STAT3 and tumor
microenvironment-related genes. J Exp Clin Cancer Res. 38:2952019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shin VY, Chen J, Cheuk IW, Siu MT, Ho CW,
Wang X, Jin H and Kwong A: Long non-coding RNA NEAT1 confers
oncogenic role in triple-negative breast cancer through modulating
chemoresistance and cancer stemness. Cell Death Dis. 10:2702019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y,
Cheng YX and Wu ZQ: Discovery of a natural small-molecule compound
that suppresses tumor EMT, stemness and metastasis by inhibiting
TGFβ/BMP signaling in triple-negative breast cancer. J Exp Clin
Cancer Res. 38:1342019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang Q, Mao Z and Sun J: NF-κB
inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage
induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder
cancer cells. Gene. 710:91–97. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mitra T, Prasad P, Mukherjee P, Chaudhuri
SR, Chatterji U and Roy SS: Stemness and chemoresistance are
imparted to the OC cells through TGFβ1 driven EMT. J Cell Biochem.
119:5775–5787. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zheng X, Zhang Y, Liu Y, Fang L, Li L, Sun
J, Pan Z, Xin W and Huang P: HIF-2α activated lncRNA NEAT1 promotes
hepatocellular carcinoma cell invasion and metastasis by affecting
the epithelial-mesenchymal transition. J Cell Biochem.
119:3247–3256. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fu JW, Kong Y and Sun X: Long noncoding
RNA NEAT1 is an unfavorable prognostic factor and regulates
migration and invasion in gastric cancer. J Cancer Res Clin Oncol.
142:1571–1579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW and Liu XS:
Integrative analyses reveal a long noncoding RNA-mediated sponge
regulatory network in prostate cancer. Nat Commun. 7:109822016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ji S, Wang S, Zhao X and Lv L: Long
noncoding RNA NEAT1 regulates the development of osteosarcoma
through sponging miR-34a-5p to mediate HOXA13 expression as a
competitive endogenous RNA. Mol Genet Genomic Med. 7:e6732019.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gibson MC and Perrimon N: Apicobasal
polarization: Epithelial form and function. Curr Opin Cell Biol.
15:747–752. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jurkiewicz D, Michalec K, Skowronek K and
Nałęcz KA: Tight junction protein ZO-1 controls organic
cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase
C-dependent way. Biochim Biophys Acta Mol Cell Res. 1864:797–805.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Abraham V, Chou ML, George P, Pooler P,
Zaman A, Savani RC and Koval M: Heterocellular gap junctional
communication between alveolar epithelial cells. Am J Physiol Lung
Cell Mol Physiol. 280:L1085–L1093. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Guillemot L, Paschoud S, Pulimeno P,
Foglia A and Citi S: The cytoplasmic plaque of tight junctions: A
scaffolding and signalling center. Biochim Biophys Acta.
1778:601–613. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Doi Y, Yashiro M, Yamada N, Amano R, Noda
S and Hirakawa K: VEGF-A/VEGFR-2 signaling plays an important role
for the motility of pancreas cancer cells. Ann Surg Oncol.
19:2733–2743. 2012. View Article : Google Scholar : PubMed/NCBI
|
